Guardant Health sues rival Natera over cancer-testing trade secrets
Medical diagnostics company Guardant Health has sued rival Natera in California federal court for allegedly stealing trade ...
NBC Los Angeles20h
Once high-flying Bluebird Bio sells itself to private equity after tough times for the gene therapy maker
Bluebird Bio will sell itself to private equity firms Carlyle and SK Capital for about $30 million, the company said Friday.